GlaxoSmithKline Biologicals s.a.;Glaxo Group Limited
发明人:
Brown, James,Mettens, Pascal,Murphy, Dennis
申请号：
AU2009273132
公开号：
AU2009273132B2
申请日:
2009.07.24
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
The present invention is directed to a polypeptide which comprises: (i) an Rv2386c protein sequence； (ii) a variant of an Rv2386c protein sequence； or (iii) an immunogenic fragment of an Rv2386c protein sequence. In other aspects the invention is directed to associated polynucleotides, fusion proteins and methods for the treatment or prevention of tuberculosis.
